生科新闻, 更新时间: 2005年9月6日
  由美国生科集团 (BVTech, Inc.) 主办
  
Pharmos对大麻 (cannabinoid) 受体 II 激动剂进行第一期临床测试
2005-9-6
  

众所周知大麻具有止痛效果,但是也可引起上瘾等神经性副作用。Pharmos 希望人工合成的特异CB2 受体激动剂,仍具有止痛作用,但没有副作用。此为第一期临床测试。如果成功,他们将进行神经痛以及手术后疼痛的二期临床试验。


The scientific community has suggested for years that substances similar to or derived from marijuana, known as cannabinoids, could treat pain. Now, careful studies show that cannabinoids directly interfere with pain signaling in the nervous system. Compounds that display high affinity for the CB2 receptor may offer avenues for harnessing the analgesic effect of CB-receptor agonists while avoiding the psychotropic and other adverse events seen with cannabinoid structures.

Source:YAHOO


 

Bioinformatics, sequence analysis; GCG; Life Science News; Drug Discovery.
生命科学进展新闻网
生科新闻网是反映生命科学研究进展的新闻网站。致力于为学术界和工业界的生命科学研究人员和大专院校师生提供及时, 准确的新闻和研究动态。为促进科技交流,尽其绵薄之力。
This is a web site of life science news in Chinese. It provides news and research trens in life sciences and drug discovery. This site is updated continuously throughout the day.
关于我们 | 投稿中心 | 广告刊登

生科集团所发布的任何消息和评论仅供读者参考。 欢迎投稿。

Copyright 2005 BVTech, Inc. All Rights Reserved